SCHEMBL382079

SCHEMBL382079

Brc1ccc(N2CCCC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.58
USP2 O75604 2/20 0.58
ALDH1A1 P00352 6/20 0.54
L3MBTL1 Q9Y468 5/20 0.54
MAPT P10636 5/20 0.54
ALOX15 P16050 3/20 0.54
MEN1 O00255 3/20 0.54
KDM4E B2RXH2 2/20 0.54
POLB P06746 2/20 0.54
GAA P10253 2/20 0.54
NPC1 O15118 2/20 0.54
TP53 P04637 2/20 0.54
RAB9A P51151 2/20 0.54
HSD17B10 Q99714 2/20 0.54
THRB P10828 1/20 0.54
HTT P42858 1/20 0.54
RECQL P46063 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
CHKA P35790 1/20 0.52
TRIM24 O15164 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2703274 0.97 ALDH1A1 (0.58) KMT2AUSP2ALDH1A1L3MBTL1MAPT
SCHEMBL539280 0.97 ALDH1A1 (0.58) KMT2AUSP2ALDH1A1L3MBTL1MAPT
SCHEMBL10401247 0.97 KMT2A (0.56) KMT2AUSP2ALDH1A1L3MBTL1MAPT
SCHEMBL23705658 0.95 KMT2A (0.53) KMT2AUSP2ALDH1A1L3MBTL1MAPT
Methyl Alcohol SCHEMBL10664077 0.93 KMT2A (0.57) KMT2AUSP2ALDH1A1L3MBTL1MAPT
SCHEMBL31252540 0.89 AKR1C3 (0.57) KMT2AUSP2ALDH1A1MAPTKDM4E
SCHEMBL2174173 0.86 ALDH1A1 (0.67) KMT2AUSP2ALDH1A1L3MBTL1MAPT
Hydrochloric Acid SCHEMBL29475563 0.83 ALDH1A1 (0.71) KMT2AUSP2ALDH1A1L3MBTL1MAPT
SCHEMBL6887590 0.83 ALDH1A1 (0.71) KMT2AUSP2ALDH1A1L3MBTL1MAPT
SCHEMBL29173466 0.83 AKR1C3 (0.57) KMT2AUSP2ALDH1A1MAPTALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 252 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119060283-B Ecological self-hardening furan resin with controllable curing speed 江苏华岗材料科技集团有限公司 2025-04-11 CN claimed
CN-119060283-A Ecological self-hardening furan resin with controllable curing speed 江苏华岗材料科技发展有限公司 2024-12-03 CN claimed
CN-122010906-A Aromatic heterocyclic derivative with S1P receptor modulating activity, and preparation method and application thereof 沈阳药科大学 2026-05-12 CN disclosed
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 US disclosed
EP-4674852-A1 PREPARATION METHOD FOR AND USE OF DIHYDROTHIENOPYRIMIDINE DERIVATIVE Innovstone Therapeutics Limited (CN) 2026-01-07 EP disclosed
US-20250230169-A1 Phosphoinositide 3-Kinase Inhibitors with a Zinc Binding Moiety CURIS INC (US) 2025-07-17 US disclosed
CN-119060283-B Ecological self-hardening furan resin with controllable curing speed 江苏华岗材料科技集团有限公司 2025-04-11 CN disclosed
CN-119060283-A Ecological self-hardening furan resin with controllable curing speed 江苏华岗材料科技发展有限公司 2024-12-03 CN disclosed
CN-118871444-A Preparation method and application of dihydro-thienopyrimidine derivative 上海翊石医药科技有限公司 2024-10-29 CN disclosed
WO-2024179493-A1 PREPARATION METHOD FOR AND USE OF DIHYDROTHIENOPYRIMIDINE DERIVATIVE 上海翊石医药科技有限公司 2024-09-06 WO disclosed
CN-114025847-B Compounds and compositions as modulators of TLR signaling 神经孔疗法股份有限公司 2024-05-24 CN disclosed
US-4536401-A ANTIPROGESTATION AND ANTIMINERALOCORTICORD EFFECTS SCHERING AKTIENGESELLSCHAFT (DE) 1985-08-20 US disclosed
EP-0147361-A2 11-Beta-aryl-estradienes, their preparation and pharmaceutical compositions containing them SCHERING AKTIENGESELLSCHAFT (DE) 1985-07-03 EP disclosed
US-4519946-A ANTIARTHRITIC, ANTIDIABETIC, ANTISECRETORY, AND HYPOTENSIVE AGENTS ROUSSEL UCLAF (FR) 1985-05-28 US disclosed
EP-0057115-B1 STEROID DERIVATIVES SUBSTITUTED IN THE 11-BETA POSITION, PROCESS FOR THEIR PREPARATION, THEIR UTILIZATION AS MEDICAMENTS AND COMPOSITIONS CONTAINING THEM ROUSSEL-UCLAF (FR) 1985-03-20 EP disclosed
EP-0116974-A1 11-Beta-aryl-estradienes, process for their preparation and pharmaceutical compositions containing them SCHERING AKTIENGESELLSCHAFT (DE) 1984-08-29 EP disclosed
EP-0110434-A1 Steroid intermediates substituted at position 11, and process for their preparation ROUSSEL-UCLAF (FR) 1984-06-13 EP disclosed
US-4447424-A ANTIFERTILITY, ANTIINFLAMMATORY AGENT, HORMONE INHIBITOR ROUSSEL UCLAF (FR) 1984-05-08 US disclosed
US-4386085-A ANTIGLUCOCORTICOIDS ROUSSELL UCLAF (FR) 1983-05-31 US disclosed
EP-0057115-A2 Steroid derivatives substituted in the 11-beta position, process for their preparation, their utilization as medicaments and compositions containing them ROUSSEL-UCLAF (FR) 1982-08-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK KMT2A 3400/4885USP2 2048/4885ALDH1A1 290/4885
US-20250230169-A1 Phosphoinositide 3-Kinase Inhibitors with a Zinc Binding Moiety BAZ2A, BAZ2B, PI4KB KMT2A 373/4885USP2 1980/4885ALDH1A1 3415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.